3 Indian Firms To Make, Sell US's Eli Lilly's Baricitinib Drug For Covid Treatment
India News | Reuters | Monday May 10, 2021
Eli Lilly and Co said on Monday it had signed licensing agreements with three Indian generic drugmakers to expand the availability of its arthritis drug baricitinib in the country for treating COVID-19 patients.
Cipla To Make, Sell US's Eli Lilly's Baricitinib Drug For Covid Treatment
India News | Reuters | Monday May 10, 2021
Indian drugmaker Cipla Ltd said on Monday it has entered into a licensing agreement with U.S. company Eli Lilly and Co to make and sell Lilly's arthritis drug baricitinib for the treatment of COVID-19 patients.
Under Trial Arthritis Drug Saves Coronavirus Patient's Life In Mumbai
India News | Written by Saurabh Gupta, Edited by Nandini Gupta | Tuesday June 9, 2020
With the Coronavirus case load increasing in India and overwhelming healthcare systems across states, stories of recovery and hope from severely ill patients have become as important as exercising caution and boosting one's immunity.
China Approves Roche Arthritis Drug To Treat Some Coronavirus Patients
World News | Reuters | Wednesday March 4, 2020
China will use a Roche Holding AG arthritis drug to treat some coronavirus patients in severe conditions, health authorities said on Wednesday, as the country seeks to build up treatment regimens to help the infected recover.
Arthritis Drug May Help Treat Rare Eye Disease: Study
Health | Press Trust of India | Tuesday October 11, 2016
A popular rheumatoid arthritis medication may effectively treat non-infectious uveitis, a rare eye disease that can lead to loss of vision, a new study has claimed.
Aurobindo Gets US Regulator Nod for Epilepsy, Arthritis Drugs
Business | Press Trust of India | Tuesday February 2, 2016
Aurobindo Pharma on Tuesday said it has received final approval from the US health regulator for generic versions of Levetiracetam injection used for treating epilepsy as well as anti-arthritis drug Celecoxib.
Government Rejects Patent on Pfizer's Arthritis Drug
Business | Thomson Reuters | Monday September 7, 2015
Government has again denied Pfizer Inc a patent on its rheumatoid arthritis drug tofacitinib, the latest setback for a multinational drugmaker seeking to enforce its intellectual property rights in the country.
Epirus, Ranbaxy Win India Approval for Arthritis Drug Copy
Business | Tuesday September 16, 2014
The market for copycat biotech drugs, known as biosimilars, is becoming more lucrative as patents expire on older, high-priced antibody drugs that rank among the pharmaceutical industry's biggest sellers.
3 Indian Firms To Make, Sell US's Eli Lilly's Baricitinib Drug For Covid Treatment
India News | Reuters | Monday May 10, 2021
Eli Lilly and Co said on Monday it had signed licensing agreements with three Indian generic drugmakers to expand the availability of its arthritis drug baricitinib in the country for treating COVID-19 patients.
Cipla To Make, Sell US's Eli Lilly's Baricitinib Drug For Covid Treatment
India News | Reuters | Monday May 10, 2021
Indian drugmaker Cipla Ltd said on Monday it has entered into a licensing agreement with U.S. company Eli Lilly and Co to make and sell Lilly's arthritis drug baricitinib for the treatment of COVID-19 patients.
Under Trial Arthritis Drug Saves Coronavirus Patient's Life In Mumbai
India News | Written by Saurabh Gupta, Edited by Nandini Gupta | Tuesday June 9, 2020
With the Coronavirus case load increasing in India and overwhelming healthcare systems across states, stories of recovery and hope from severely ill patients have become as important as exercising caution and boosting one's immunity.
China Approves Roche Arthritis Drug To Treat Some Coronavirus Patients
World News | Reuters | Wednesday March 4, 2020
China will use a Roche Holding AG arthritis drug to treat some coronavirus patients in severe conditions, health authorities said on Wednesday, as the country seeks to build up treatment regimens to help the infected recover.
Arthritis Drug May Help Treat Rare Eye Disease: Study
Health | Press Trust of India | Tuesday October 11, 2016
A popular rheumatoid arthritis medication may effectively treat non-infectious uveitis, a rare eye disease that can lead to loss of vision, a new study has claimed.
Aurobindo Gets US Regulator Nod for Epilepsy, Arthritis Drugs
Business | Press Trust of India | Tuesday February 2, 2016
Aurobindo Pharma on Tuesday said it has received final approval from the US health regulator for generic versions of Levetiracetam injection used for treating epilepsy as well as anti-arthritis drug Celecoxib.
Government Rejects Patent on Pfizer's Arthritis Drug
Business | Thomson Reuters | Monday September 7, 2015
Government has again denied Pfizer Inc a patent on its rheumatoid arthritis drug tofacitinib, the latest setback for a multinational drugmaker seeking to enforce its intellectual property rights in the country.
Epirus, Ranbaxy Win India Approval for Arthritis Drug Copy
Business | Tuesday September 16, 2014
The market for copycat biotech drugs, known as biosimilars, is becoming more lucrative as patents expire on older, high-priced antibody drugs that rank among the pharmaceutical industry's biggest sellers.
................................ Advertisement ................................
................................ Advertisement ................................
